Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
topic_facet:"Medical Condition: Non-small Cell Lung Cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (379)
1
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007) : A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) in Participants With Treatment-naïve, Metastatic Nonsmall Cell Lung Cancer (NSCLC) Whose Tumors Have a Tumor Proportion Score (TPS) Greater Than or Equal to 1% (LEAP-007)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC : Hypofractionated Radiotherapy Followed by Hypofractionated Boost With Weekly Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: A Prospective, Single Arm Phase II Study
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
3
Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy : An Active Surveillance to Monitor the Real World Safety in Indian Patients Prescribed Nintedanib for the Treatment of Locally Advanced, Metastatic or Locally Recurrent Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Tumor Histology After First Line Chemotherapy
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC : A Phase Ib/II Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With Advanced NSCLC
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1 : A Phase Ib/II ,Single Arm, Multi-Center, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of JAB-21822 in Advanced or Metastatic Non-small Cell Lung Cancer With a KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit : Phase 3 Multicentre, Prospective, Interventional Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit, From Patients With Non-Small Cell Lung Cancer, Screened in Clinical Study (Protocol No. 20190009).
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance : Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR Clinical Study)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients : A Randomized Trial of Medically-Inoperable Stage 1 Non-small Cell Lung Cancer Patients Comparing Stereotactic Body Radiotherapy Versus Conventional Radiotherapy
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC : Sequential Envafolimab Immunotherapy After Patients With ctDNA EGFR Mutation Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive Non-small-cell Lung Cancer:Efficacy and Safety Clinical Trial
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer : An Open-Label, Singe Arm, Multicenter Study to Investigate the Safety and Efficacy of Atezolizumab (Tecentriq) in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Thema: Medical Condition: Non-small Cell Lung Cancer
Medienart
379
Aufsätze
379
E-Artikel
379
E-Ressourcen
Zeitschriftentitel
379
ClinicalTrials.gov
Thema
379
610
Carcinoma, Non-Small-Cell Lung
Medical Condition: Non-small Cell Lung Cancer
337
Lung Neoplasms
322
Study Type: Interventional
156
Phase: Phase 2
142
Recruitment Status: Completed
90
Recruitment Status: Unknown status
51
Study Type: Observational
49
Recruitment Status: Terminated
44
Recruitment Status: Recruiting
43
Phase: Phase 3
36
Phase: Phase 1
24
Phase: Phase 1/Phase 2
19
Recruitment Status: Not yet recruiting
16
Recruitment Status: Active, not recruiting
15
Recruitment Status: Withdrawn
9
Phase: Phase 1, Phase 2
8
Phase: Phase 4
7
Phase: Phase 2/Phase 3
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
121
2020-
254
2010-2019
4
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
379
Englisch
Haven't found what you're looking for?
Wird geladen...